Cosentyx snrdy 300MG dose-2PENML
Ended Awarded Last action
- Contract number
- SPE2DR26F9JX3
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $43,093
Award facts
- Contract value 100% obligated
- $43,093.28 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $43,093.28 delivery order to AmerisourceBergen Drug Corp on January 6, 2026, for the supply of Cosentyx (secukinumab) 300mg dose auto-injector pens. This is a firm fixed-price, competitively awarded contract with no set-aside designation, with an ultimate completion date of January 7, 2026. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's parent company Cencora, Inc.'s larger Indefinite Delivery Contract with DLA Troop Support Medical, valued at up to $999,999,999 and running through December 31, 2031, which serves as the primary vehicle for delivering comprehensive pharmaceutical products and medical supplies to support military healthcare programs globally.
Cosentyx is a biologic immunosuppressant used to treat autoimmune inflammatory conditions, making this pharmaceutical supply critical for military medical treatment facilities and veteran healthcare programs. The delivery order demonstrates AmerisourceBergen's established capability as a major pharmaceutical distributor to fulfill federal procurement requirements through the DLA Medical Supply Chain. The broader IDC vehicle enables efficient procurement of specialty medications, brand-name and generic drugs, vaccines, and medical supplies across multiple therapeutic domains to support the Defense Health Agency and other federal healthcare systems worldwide.
Quick answers
Who was awarded contract SPE2DR26F9JX3?
SPE2DR26F9JX3 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 6, 2026.
How much is contract SPE2DR26F9JX3 worth?
The government has obligated $43,093 on SPE2DR26F9JX3.
Is contract SPE2DR26F9JX3 an order under another contract?
Yes. SPE2DR26F9JX3 is a delivery order under SPE2DR25D2206, an indefinite delivery contract.
Was contract SPE2DR26F9JX3 competed?
The extent of competition for SPE2DR26F9JX3 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award